Evidence map›Paper›PMID 37180514›Full record

ArticleKidney international reports2023

Unmet Needs of CKD in Latin America: A Review from Expert Virtual Working Group.

Ricardo Correa-Rotter, Antonio Méndez Durán, Augusto Vallejos, Jorge Rico-Fontalvo, Ana María Cusumano, Guillermo Javier Rosa-Diez, Vicente Sánchez Polo, Helmuth Goecke, José Javier Arango, Vanessa Villavicencio Cerón and 4 more

Open access · goldAbstract read
In one paragraph

Article in Kidney international reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. [Renoprotection. About World Kidney Day].Revista medica del Instituto Mexicano del Seguro Social · 2023
    Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 6 countries.

Ricardo Correa-RotterInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México.
Antonio Méndez DuránInstituto Mexicano del Seguro Social, Ciudad de México, México.
Augusto VallejosJunín Kidney Health Center, Junín, Buenos Aires, Argentina.
Jorge Rico-FontalvoTechnology and Innovation Management, Simón Bolivar University, Barranquilla, Colombia.
Ana María CusumanoPergamino Nephrology Unit, Pergamino, Buenos Aires, Argentina.
Guillermo Javier Rosa-DiezDivision of Nephrology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Vicente Sánchez PoloInstituto Guatemalteco de Seguridad Social, Guatemala City, Guatemala.
Helmuth GoeckeHospital Naval, Viña del Mar, Chile.
José Javier ArangoFresenius Medical Care, Bogotá, Colombia.
Vanessa Villavicencio CerónHospital del IESS-Villa Renal, Portoviejo-Manabi, Ecuador.
Eliana DináHospital Metropolitano de Santiago, Santiago de los Caballeros, Dominican Republic.
Fabio Hernández FonsecaHospital San Juan de Dios, San José, Costa Rica.
Régulo Adolfo ValdésSocial Security of Panama, Ciudad de Panamá, Panamá.
Miguel VanoniHospital Clínica Kennedy, Guayaquil, Ecuador.
Hospital Italiano de Buenos Aires · ARHospital Naval Almirante Nef · CLInstituto Ecuatoriano de Enfermedades Digestivas · ECInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXKennedy Clinic Hospital · ECMexican Social Security Institute · MXUniversidad Simón Bolívar · COUniversidad Tecnológica de Santiago · DO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic kidney disease (CKD) represents a major challenge for Latin American (LatAm) because of its epidemic proportions. Therefore, the current status and knowledge of CKD in Latin America is not clearly understood. Moreover, there is a paucity of epidemiologic studies that makes the comparison across the countries even more difficult. To address these gaps, a virtual kidney expert opinion meeting of 14 key opinion leaders from Argentina, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, and Panama was held in January 2022 to review and discuss the status of CKD in various LatAm regions. The meeting discussed the following: (i) epidemiology, diagnosis, and treatment of CKD, (ii) detection and prevention programs, (iii) clinical guidelines, (iv) state of public policies about diagnosis and management of chronic kidney disease, and (v) role of innovative therapies in the management of CKD. The expert panel emphasized that efforts should be made to implement timely detection programs and early evaluation of kidney function parameters to prevent the development or progression of CKD. Furthermore, the panel discussed the importance of raising awareness among health care professionals; disseminating knowledge to the authorities, the medical community, and the general population about the kidney and cardiovascular benefits of novel therapies; and the need for timely updating of clinical practice guidelines, regulatory policies, and protocols across the region.

Indexed as

chronic kidney diseaseclinical practice guidelineskidney failurekidney replacement therapynational kidney failure registriesnational policies

Identifiers

PMID37180514
PMCPMC10166742
OpenAlexW4322505028

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.